Journal Information
Share
Share
Download PDF
More article options
Full text access
Pre-proof, online 17 July 2024
Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival. Results from the Spanish Thoracic Tumor Registry
Visits
8
Cristina Candal-Pedreira1,2, Alberto Ruano-Ravina1,2,*, Virginia Calvo de Juan2,3, Manuel Cobo2,4, Alexandra Cantero2,4, Delvys Rodríguez-Abreu2,5, Anna Estival2,5, Enric Carcereny2,6, Ainhoa Hernandez2,6, Rafael López Castro2,7, Andrea Medina2,7, Rosario García Campelo2,8, Manuel Fernández Bruno2,8, Reyes Barnabé2,9, Joaquim Bosch-Barrera2,10, Bartomeu Massutí2,11, Manuel Dómine2,12, Carlos Camps2,13, Ana Laura Ortega2,14, Mariano Provencio2
1 Area of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain
2 Spanish Lung Cancer Group, Spain
3 Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
4 Medical Oncology Intercenter Unit. Regional and Virgen de la Victoria University Hospitals. IBIMA, Málaga, Spain
5 Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain
6 Institut Català D'Oncologia Badalona- Hospital Germans Trias i Pujol, B-ARGO, IGTP, Badalona, Spain
7 Hospital Clínico Universitario de Valladolid, Valladolid, Spain
8 Complejo Hospitalario Universitario A Coruña, A Coruña, Spain
9 Hospital Universitario Virgen del Rocio, Sevilla, Spain
10 Catalan Institute of Oncology, Hospital Universitari Dr. Josep Trueta and Precision Oncology Group (OncoGIR-Pro), Institut d'Investigacions Biomèdiques de Girona (IDIBGI), Girona, Spain
11 Hospital General Universitario Dr. Balmis de Alicante, Alicante, Spain
12 Hospital Universitario Fundación Jiménez Díaz. IIS-FJD, Madrid, Spain
13 Hospital General Universitario de Valencia, Valencia, Spain
14 Hospital Universitario de Jaén, Jaén, Spain
Ver más
This item has received
Article information
ABSTRACT

Background: Early detection is crucial to improve lung cancer survival rates. Delays in diagnosis might negatively impact the prognosis of the disease. This study aims to analyze the diagnostic delay in lung cancer patients and describe if there is an association between delay and survival.

Methods: The data source used was the Thoracic Tumour Registry of the Spanish Lung Cancer Group. This analysis was restricted to lung cancer cases with information on the first date of consultation by symptoms and date of diagnosis. The delay was calculated as the number of days between the two dates. A descriptive analysis was performed, and ordinal logistic regressions were fitted with delay as the dependent variable. Kaplan-Meier survival analysis and Cox regression were performed.

Results: 22,755 cases were included. Never smokers were 1.16 (95%CI:1.06-1.27) times more likely to register longer delay than smokers. Stage 0-I-II cases had a 3.09 (95%CI:2.88-3.32) higher risk of longer delay compared to III-IV stages. Overall, 5-year survival rate after diagnosis was 23.64% (95%CI: 22.88-24.41). In those categorized as having the shortest delay 5-year survival was 17.67% (CI95%:16.31-19.07) and in the extreme delay it was 32.98% (CI95%: 31.28-34.69) (p<0.005). Adjusted mortality risk was higher in those with the shortest delay (HR 1.36, CI95%:1.30-1.43) in comparison with the extreme delay.

Conclusions: Diagnostic delay is short among Spanish lung cancer patients, indicating a relatively quick diagnostic process. Extreme delays appear to be associated with higher survival rates, possibly attributed to slow-growing tumors, earlier stage at diagnosis or basically the natural history of this disease.

Keywords:
lung cancer
lung neoplasms
diagnosis
Full text is only aviable in PDF
Copyright © 2024. The Author(s)
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?